LC
AGN

Lindbrook Capital’s Allergan plc AGN Stock Holding History

Lindbrook Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-400
Closed -$71K – 1966
2020
Q1 		$71K Sell
400
-14
-3% -$2.64K 0.03% 243
2019
Q4 		$79K Buy
414
+7
+2% +$1.26K 0.03% 303
2019
Q3 		$68K Buy
407
+89
+28% +$14.5K 0.03% 325
2019
Q2 		$53K Sell
318
-159
-33% -$22K 0.02% 410
2019
Q1 		$69K Buy
477
+64
+15% +$9.28K 0.03% 314
2018
Q4 		$55K Buy
+413
New +$67.7K 0.03% 314

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Lindbrook Capital's AGN Position: Q2 2020 in Review

Lindbrook Capital sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 400 shares — an estimated $71K sold.

Lindbrook Capital first reported a position in AGN in Q4 2018 and held it in 6 quarters. The position peaked at $79K in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Lindbrook Capital reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Lindbrook Capital sold 400 Allergan plc shares in Q2 2020, an estimated $71K.
  • Lindbrook Capital first reported a position in Allergan plc in Q4 2018 and held it in 6 quarters.
  • Lindbrook Capital's Allergan plc position peaked at $79K in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Lindbrook Capital's 13F filing for Q2 2020, filed 27 Jul 2020.